Skip to content

Drug interactions

Eliglustat + Mitomycin

Severity: Minor

Eliglustat and Mitomycin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eliglustat inhibits P-glycoprotein and may raise exposure to substrates such as mitomycin. This could increase mitomycin toxicity, notably myelosuppression.

What this interaction means in plain words

Eliglustat and Mitomycin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Eliglustat belongs to Miscellaneous; Mitomycin belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of P-glycoprotein efflux by eliglustat may increase mitomycin exposure.

What to do

Monitor blood counts and signs of mitomycin toxicity during co-administration. Reduce the mitomycin dose if adverse effects occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eliglustat and Mitomycin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eliglustat with Mitomycin?

MediHelp rates the interaction as minor. Eliglustat and Mitomycin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Eliglustat inhibits P-glycoprotein and may raise exposure to substrates such as mitomycin. This could increase mitomycin toxicity, notably myelosuppression.

How serious is the interaction between Eliglustat and Mitomycin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and signs of mitomycin toxicity during co-administration. Reduce the mitomycin dose if adverse effects occur.

What other medicines interact with Mitomycin?

MediHelp also lists interactions of Mitomycin with, for example, Bacitracin, Deferiprone, Dengue vaccine. The full list is on the Mitomycin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in